Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given a consensus rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $61.50.

Several research firms have commented on TEM. Bank of America upped their target price on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. Needham & Company LLC reissued a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a report on Wednesday. TD Cowen reaffirmed a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Guggenheim reissued a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, William Blair restated a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th.

Tempus AI Stock Down 5.9 %

Shares of Tempus AI stock opened at $61.34 on Monday. Tempus AI has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business’s 50 day simple moving average is $48.39 and its 200-day simple moving average is $50.97.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The company’s revenue for the quarter was up 75.4% compared to the same quarter last year. As a group, equities research analysts expect that Tempus AI will post -6.15 EPS for the current year.

Insider Activity

In related news, Director Nadja West sold 809 shares of the stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total value of $41,347.99. Following the completion of the transaction, the director now owns 37,705 shares in the company, valued at $1,927,102.55. This trade represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Erik Phelps sold 61,582 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total value of $5,071,893.52. Following the sale, the executive vice president now owns 153,080 shares in the company, valued at approximately $12,607,668.80. The trade was a 28.69 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,237,561 shares of company stock worth $251,210,331. Corporate insiders own 27.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. lifted its position in shares of Tempus AI by 12.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock valued at $89,000 after acquiring an additional 208 shares in the last quarter. Wells Fargo & Company MN raised its stake in Tempus AI by 13.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares during the period. Bartlett & CO. Wealth Management LLC lifted its holdings in shares of Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock valued at $39,000 after purchasing an additional 400 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Tempus AI by 10.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company’s stock worth $268,000 after buying an additional 515 shares during the period. Finally, Cherry Tree Wealth Management LLC purchased a new position in shares of Tempus AI during the first quarter valued at $31,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.